Cancer Research Center of Lyon
@crcl
Followers
1K
Following
529
Media
134
Statuses
511
The CRCL is affiliated with the University Lyon1, Inserm, CNRS and the Léon Bérard center. Its activity is entirely dedicated to oncology research.
Lyon, France
Joined December 2014
❗The 6th CRCL International Cancer Symposium will soon be held and the call for communications is now open 📅Closing date: Oct 31st Don't miss the opportunity to present and share your work at one of the biggest cancer conferences to be held in france. ➡️ https://t.co/Uvw4hpYpuT
🚨Registration is now open🚨 🎯6th CRCL International Cancer Symposium 🗓️January 29-31, 2025 📍 Lyon, France ➡️ https://t.co/Uvw4hpYpuT Don't miss the opportunity to participate in one of the most important conferences about oncology research to be held in France.
1
2
4
#ResultatScientifique🔎| Quand une protéine de l’immunité protège notre patrimoine génétique 🤝 @CNRS @CLCCLeonBerard @Inserm @UnivLyon1 @crcl ✍️ Virginie Petrilli 📕 @NAR_Open | https://t.co/I7fnxecxYv
https://t.co/9TKAd8oLGy
insb.cnrs.fr
Dans un article publié dans Nucleic Acids Research, des scientifiques ont découvert que NLRP3, une protéine connue pour protéger l’organisme lors d��u
0
3
5
Recently published: Phase I First-in-Human Study of TRK-950, an #IgG1 Antibody Specific to CAPRIN-1, in Patients with #AdvancedSolidTumors, by Philippe A. Cassier et al. https://t.co/AHN4hjVdNt
@jeanyvesblay @CLCCLeonBerard @crcl #OpenAccess
0
2
3
📅 Don't miss next week's CRCL Thematic Day! ✨A great opportunity to expand your knowledge and interact with experts in the field of #epigenetics. 🙏 Don't hesitate to share this event with your colleagues who might be interested! #Webinar #Science #Innovation #Cancer
🚨9th CRCL Thematic Day 📅 December 13th, online 🧬 Topic: Epigenetics in oncogenesis: driver, passenger, or both? We are pleased to welcome great scientists : Giacomo Cavalli, @VallotCeline, @trevoragraham ! ➡️More information : https://t.co/PDLoU41oJb
0
0
0
60 ans de l’Inserm au BarCamp à la BU sciences @UnivLyon1. Merci à Gabriel Chemin @crcl et Manon Gouez @CancerEnvironn @CLCCLeonBerard pour leur intervention
0
1
4
@CNRS @CNRS_Toulouse @UT3PaulSabatier @CbiToulouse 🏆 @CNRSbiologie et la Fondation CNRS félicitent Julie Leca, chercheuse en oncohématologie au @CRCL pour l'obtention du prix Biologie des cancers ! 🤝 @CNRS @CNRS_dr07 @Inserm @CLCCLeonBerard @UnivLyon1 📽️ Découvrez son portrait : https://t.co/qchE5NsXl1
2
2
6
Finally out 😃! Many thanks to all the contributors ! @crcl @iNeuroMyoGene @NatureComms
https://t.co/0jKLGDYKao
0
8
28
🚨Deadline Extended for #CRCLSymposium Abstracts! An extra chance to share your insights with the community ! Submit your abstract by 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟭𝟳𝘁𝗵 to join leading experts in cancer research at our 6th edition in Lyon. ➡️registration: https://t.co/hIxYylrTRx
0
0
0
🚨9th CRCL Thematic Day 📅 December 13th, online 🧬 Topic: Epigenetics in oncogenesis: driver, passenger, or both? We are pleased to welcome great scientists : Giacomo Cavalli, @VallotCeline, @trevoragraham ! ➡️More information : https://t.co/PDLoU41oJb
0
0
2
⏰ Only 10 days left to submit an abstract and benefit from the early registration fees ! #CRCLSymposium
#CRCLSymposium 🚨Don't miss the 10/31 deadline: closing of the call for papers and of the early registration fees. ✨This edition promises to be particularly exciting, with an exceptional line-up of speakers ! ➡️ https://t.co/Uvw4hpYpuT
0
4
5
#ResultatScientifique 🔎 | Thérapie anti-cancéreuse : une nouvelle approche prometteuse 🤝 @CNRS @CNRS_dr07 @Inserm @UnivLyon1 @CLCCLeonBerard @crcl ✍️ Isabelle Coste 📕 @NatureComms | https://t.co/OVvog9Znjz
https://t.co/1XHbVq5wJj
0
6
8
#CRCLSymposium 🚨Don't miss the 10/31 deadline: closing of the call for papers and of the early registration fees. ✨This edition promises to be particularly exciting, with an exceptional line-up of speakers ! ➡️ https://t.co/Uvw4hpYpuT
0
1
6
💨 🕜 Time flies, the CRCL International Symposium will be held in less than 5 months ! 👉 don't forget the October 31st deadline to submit an abstract and benefit from the preferential registration rate. ➡ Registration & abstract submission: https://t.co/Uvw4hpYpuT
1
3
6
🚨Superbe étude réalisée au @crcl par @julienCMarie1 et son équipe. 🔎Des lymphocytes induisent le cancer ! C'est publié aujourd'hui dans @NatImmunol
https://t.co/PuUQfNaM0k Félicitations aux auteurs 👏👏
nature.com
Nature Immunology - Here, the authors show that there is a pretumorigenic TH17 subset in the intestines that can convert to being tumorigenic under the control of KLF6 and that this process can be...
#Communiqué 🗞️ Dans une nouvelle étude, des scientifiques ont identifié des lymphocytes impliqués dans les processus inflammatoires et qui seraient en cause dans la génération de cancers. 👉 https://t.co/CGIJoOPJyI
0
0
6
#Communiqué 🗞️ Dans une nouvelle étude, des scientifiques ont identifié des lymphocytes impliqués dans les processus inflammatoires et qui seraient en cause dans la génération de cancers. 👉 https://t.co/CGIJoOPJyI
0
21
33
🚨#JobOpening - Postdoctoral position Our "Adhesion and signaling in metastatic melanoma" Team (@AblainLab) is looking for highly motivated postdoctoral fellow in cancer biology. 📷See the complete job description on : https://t.co/GGe5kJkT7l
0
3
3
🚨#JobOpening - Postdoctoral position Our CISTAR Team - Cancer immune surveillance and therapeutic targeting - is looking for highly motivated scientist with a background in immuno-oncology. 🔎See the complete job description on : https://t.co/GGe5kJkT7l
0
1
1
📢 Conf de clôture Chaire SHS @Institut_cancer @BesleSylvain 📅 26 Nov 2024 Lyon « Enjeux sociaux de la médecine personnalisée et l’innovation en cancérologie » Gratuit💻 https://t.co/f8wvvneuWK 🔊A diffuser !! @canceroCLARA @CLCCLeonBerard @UnivLyon1 @LYriCAN_SIRIC @crcl
0
4
6
🚨8th CRCL Thematic Day ➡️When fighting cancer becomes physical 🗓️June 28th 📍Videoconference 📢Free attendance ! More information and link : https://t.co/TNiJPiOxhh
0
2
1
📢#recrutement Notre équipe "mort cellulaire et cancers de l'enfant" recrute un(e) ingénieur(e) d'étude. ✨Rejoignez une équipe dynamique qui vise à définir des stratégies thérapeutiques innovantes et plus efficaces pour les enfants atteints de cancer. https://t.co/uSWrR7LTFc
0
4
2